Which closed-end funds own Neogenomics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $29.6M. Security type: common equity. Country: United States. CUSIP 64049M209 · ISIN US64049M2098 · ticker NEO.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 1.48% | $15.6M | 1,069,634 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.92% | $12.6M | 861,891 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.58% | $1.3M | 90,000 sh | $228M | NAV unavailable | Jun 30, 2026 |
| GGZ Gabelli Global Small & Mid Cap Value Trust | Global Equity | 0.05% | $80.2K | 5,500 sh | $165M | 11.2% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.00% | $13.9K | 1,325 sh | $631M | 14.1% discount | May 29, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: NeoGenomics Inc.
Issuer-level search for “NEO” → · Compare two funds’ portfolios →